Vioxx GMP Violations Cited In FDA Warning Letter Spur Merck Retraining
Executive Summary
Inadequate sampling, testing, investigation and documentation of Merck's Vioxx (rofecoxib) lots are among good manufacturing practice violations cited in a June 27 FDA warning letter.
You may also be interested in...
AstraZeneca discontinues Elavil
AstraZeneca has discontinued its antidepressant Elavil (amitriptyline). The injection form is no longer available and the tablet inventory is expected to be depleted by the end of the year. The drug, which was manufactured by Merck, was cited for GMP problems in 2000 (1"The Pink Sheet" July 17, 2000, p. 24)...
AstraZeneca discontinues Elavil
AstraZeneca has discontinued its antidepressant Elavil (amitriptyline). The injection form is no longer available and the tablet inventory is expected to be depleted by the end of the year. The drug, which was manufactured by Merck, was cited for GMP problems in 2000 (1"The Pink Sheet" July 17, 2000, p. 24)...
Merck Sterile Product Manufacturing Difficulties Affect Cancidas, Timoptic
Merck's recently launched antifungal Cancidas is in short supply as a result of manufacturing difficulties affecting the company's sterile product lines